MDxHealth S.A.
MXDHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $90 | $70 | $37 | $22 |
| % Growth | 28.3% | 89.4% | 66.6% | – |
| Cost of Goods Sold | $35 | $26 | $18 | $12 |
| Gross Profit | $55 | $44 | $19 | $11 |
| % Margin | 61.2% | 62.6% | 51.9% | 47.5% |
| R&D Expenses | $11 | $6 | $8 | $6 |
| G&A Expenses | $55 | $23 | $24 | $27 |
| SG&A Expenses | $61 | $60 | $50 | $30 |
| Sales & Mktg Exp. | $6 | $37 | $27 | $3 |
| Other Operating Expenses | $8 | $5 | -$1 | $2 |
| Operating Expenses | $80 | $71 | $57 | $37 |
| Operating Income | -$25 | -$27 | -$38 | -$27 |
| % Margin | -27.5% | -38.9% | -102.3% | -120.7% |
| Other Income/Exp. Net | -$13 | -$16 | -$6 | -$2 |
| Pre-Tax Income | -$38 | -$43 | -$44 | -$29 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$38 | -$43 | -$44 | -$29 |
| % Margin | -42.3% | -61.4% | -118.9% | -130.4% |
| EPS | -0.78 | -1.66 | -2.78 | -2.38 |
| % Growth | 53% | 40.3% | -16.8% | – |
| EPS Diluted | -1.16 | -1.66 | -2.78 | -2.38 |
| Weighted Avg Shares Out | 49 | 26 | 16 | 12 |
| Weighted Avg Shares Out Dil | 49 | 26 | 16 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $8 | $6 | $3 | $2 |
| Depreciation & Amortization | $8 | $7 | $5 | $3 |
| EBITDA | -$22 | -$30 | -$36 | -$24 |
| % Margin | -24.5% | -43.4% | -98.2% | -108.3% |